Dexcom (DXCM) Gross Profit Growth (1y) (2011 - 2026)
Dexcom (DXCM) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 15.74% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 27.39% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -1.74% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.30% |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 8.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.39% |
| Dec 31, 2025 | 20.88% |
| Sep 30, 2025 | 23.17% |
| Jun 30, 2025 | 9.91% |
| Mar 31, 2025 | 4.82% |
| Dec 31, 2024 | -0.12% |
| Sep 30, 2024 | -4.73% |
| Jun 30, 2024 | 14.70% |
| Mar 31, 2024 | 21.47% |
| Dec 31, 2023 | 21.30% |
| Sep 30, 2023 | 26.12% |
| Jun 30, 2023 | 21.56% |
| Mar 31, 2023 | 16.20% |
| Dec 31, 2022 | 14.54% |
| Sep 30, 2022 | 10.58% |
| Jun 30, 2022 | 7.77% |
| Mar 31, 2022 | 15.76% |
| Dec 31, 2021 | 18.42% |
| Sep 30, 2021 | 31.29% |
| Jun 30, 2021 | 46.81% |